US 7585852
Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation
granted A61KA61K51/041A61K51/0482
Quick answer
US patent 7585852 (Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation) held by Solidago AG expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Solidago AG
- Grant date
- Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K51/041, A61K51/0482, A61K51/0497, A61P